Pegfilgrastim-induced pain in patients with lymphoma

Oncol Nurs Forum. 2014 Mar 1;41(2):212-4. doi: 10.1188/14.ONF.212-214.
No abstract available

Keywords: acute care; ambulatory care and office nursing; and hematology; chemotherapy; clinical practice; leukemia; lymphomas.

Publication types

  • Case Reports

MeSH terms

  • Acute Pain / chemically induced*
  • Acute Pain / drug therapy
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Antibodies, Monoclonal, Murine-Derived / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Etoposide / administration & dosage
  • Female
  • Filgrastim
  • Granulocyte Colony-Stimulating Factor / administration & dosage
  • Granulocyte Colony-Stimulating Factor / adverse effects*
  • Humans
  • Lymphoma, Large B-Cell, Diffuse / drug therapy*
  • Lymphoma, Large B-Cell, Diffuse / nursing
  • Middle Aged
  • Neutropenia / drug therapy*
  • Neutropenia / nursing
  • Oncology Nursing
  • Polyethylene Glycols
  • Prednisone / administration & dosage
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / adverse effects
  • Rituximab
  • Vincristine / administration & dosage

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antibodies, Monoclonal, Murine-Derived
  • Recombinant Proteins
  • Granulocyte Colony-Stimulating Factor
  • pegfilgrastim
  • Polyethylene Glycols
  • Rituximab
  • Vincristine
  • Etoposide
  • Doxorubicin
  • Cyclophosphamide
  • Filgrastim
  • Prednisone

Supplementary concepts

  • EPOCH protocol